These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28450398)

  • 101. Proper glycosylation and phosphorylation of the type A natriuretic peptide receptor are required for hormone-stimulated guanylyl cyclase activity.
    Koller KJ; Lipari MT; Goeddel DV
    J Biol Chem; 1993 Mar; 268(8):5997-6003. PubMed ID: 8095500
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Allosteric modification, the primary ATP activation mechanism of atrial natriuretic factor receptor guanylate cyclase.
    Duda T; Yadav P; Sharma RK
    Biochemistry; 2011 Feb; 50(7):1213-25. PubMed ID: 21222471
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide.
    Thompson IR; Chand AN; King PJ; Ansorge O; Karavitaki N; Jones CA; Rahmutula D; Gardner DG; Zivkovic V; Wheeler-Jones CP; McGonnell IM; Korbonits M; Anderson RA; Wass JA; McNeilly AS; Fowkes RC
    Endocr Relat Cancer; 2012 Aug; 19(4):497-508. PubMed ID: 22645228
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C).
    Murthy KS; Makhlouf GM
    J Biol Chem; 1999 Jun; 274(25):17587-92. PubMed ID: 10364194
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B.
    Potthast R; Abbey-Hosch SE; Antos LK; Marchant JS; Kuhn M; Potter LR
    J Biol Chem; 2004 Nov; 279(47):48513-9. PubMed ID: 15371450
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.
    Sangaralingham SJ; Whig K; Peddibhotla S; Kirby RJ; Sessions HE; Maloney PR; Hershberger PM; Mose-Yates H; Hood BL; Vasile S; Pan S; Zheng Y; Malany S; Burnett JC
    Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34930837
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.
    Egbert JR; Shuhaibar LC; Edmund AB; Van Helden DA; Robinson JW; Uliasz TF; Baena V; Geerts A; Wunder F; Potter LR; Jaffe LA
    Development; 2014 Sep; 141(18):3594-604. PubMed ID: 25183874
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The cloning of a Caenorhabditis elegans guanylyl cyclase and the construction of a ligand-sensitive mammalian/nematode chimeric receptor.
    Baude EJ; Arora VK; Yu S; Garbers DL; Wedel BJ
    J Biol Chem; 1997 Jun; 272(25):16035-9. PubMed ID: 9188508
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.
    Shuhaibar LC; Kaci N; Egbert JR; Horville T; Loisay L; Vigone G; Uliasz TF; Dambroise E; Swingle MR; Honkanen RE; Biosse Duplan M; Jaffe LA; Legeai-Mallet L
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33986191
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Dominant negative mutations of the guanylyl cyclase-A receptor. Extracellular domain deletion and catalytic domain point mutations.
    Thompson DK; Garbers DL
    J Biol Chem; 1995 Jan; 270(1):425-30. PubMed ID: 7814405
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Sensitivity of the Natriuretic Peptide/cGMP System to Hyperammonaemia in Rat C6 Glioma Cells and GPNT Brain Endothelial Cells.
    Regan JT; Mirczuk SM; Scudder CJ; Stacey E; Khan S; Worwood M; Powles T; Dennis-Beron JS; Ginley-Hidinger M; McGonnell IM; Volk HA; Strickland R; Tivers MS; Lawson C; Lipscomb VJ; Fowkes RC
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672024
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.
    Yoder AR; Stone MD; Griffin TJ; Potter LR
    Biochemistry; 2010 Nov; 49(47):10137-45. PubMed ID: 20977274
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.
    Wagner BM; Robinson JW; Lin YW; Lee YC; Kaci N; Legeai-Mallet L; Potter LR
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33784257
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice.
    Wagner BM; Robinson JW; Healy CL; Gauthier M; Dickey DM; Yee SP; Osborn JW; O'Connell TD; Potter LR
    FASEB J; 2022 Jan; 36(1):e22069. PubMed ID: 34859913
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Molecular basis for GTP recognition by light-activated guanylate cyclase RhGC.
    Butryn A; Raza H; Rada H; Moraes I; Owens RJ; Orville AM
    FEBS J; 2020 Jul; 287(13):2797-2807. PubMed ID: 31808997
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Vicinal glutamates are better phosphomimetics: Phosphorylation is required for allosteric activation of guanylyl cyclase-A.
    Otto NM; Potter LR
    Front Mol Neurosci; 2022; 15():1012784. PubMed ID: 36407758
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux.
    Khan S; Ali RH; Abbasi S; Nawaz M; Muhammad N; Ahmad W
    BMC Med Genet; 2012 Jun; 13():44. PubMed ID: 22691581
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Mutational analysis of disulfide bridges in the type C atrial natriuretic peptide receptor.
    Itakura M; Iwashina M; Mizuno T; Ito T; Hagiwara H; Hirose S
    J Biol Chem; 1994 Mar; 269(11):8314-8. PubMed ID: 8132555
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Atrial natriuretic factor receptor guanylate cyclase signaling: new ATP-regulated transduction motif.
    Duda T; Bharill S; Wojtas I; Yadav P; Gryczynski I; Gryczynski Z; Sharma RK
    Mol Cell Biochem; 2009 Apr; 324(1-2):39-53. PubMed ID: 19137266
    [TBL] [Abstract][Full Text] [Related]  

  • 120. ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency.
    Dickey DM; Potter LR
    Clin Chem; 2011 Sep; 57(9):1272-8. PubMed ID: 21768217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.